Published in Transplantation on September 15, 2011
Cyst fluid analysis in the differential diagnosis of pancreatic cystic lesions: a pooled analysis. Gastrointest Endosc (2005) 3.28
Fibrin sealant for prevention of resection surface-related complications after liver resection: a randomized controlled trial. Ann Surg (2012) 3.28
Novel association in chromosome 4q27 region with rheumatoid arthritis and confirmation of type 1 diabetes point to a general risk locus for autoimmune diseases. Am J Hum Genet (2007) 2.89
The impact of intraoperative transfusion of platelets and red blood cells on survival after liver transplantation. Anesth Analg (2008) 2.45
Hemostasis and thrombosis in patients with liver disease: the ups and downs. J Hepatol (2010) 2.41
Telomere length of circulating leukocytes is decreased in patients with chronic heart failure. J Am Coll Cardiol (2007) 2.36
Safety and efficacy of a single bolus administration of recombinant factor VIIa in liver transplantation due to chronic liver disease. Liver Transpl (2005) 2.35
Chronic hepatitis E virus infection in liver transplant recipients. Liver Transpl (2008) 2.30
Management of nonneoplastic portal vein thrombosis in the setting of liver transplantation: a systematic review. Transplantation (2012) 2.26
Lectin complement pathway gene profile of donor and recipient determine the risk of bacterial infections after orthotopic liver transplantation. Hepatology (2010) 2.25
Shared decision making in transplantation: how patients see their role in the decision process of accepting a donor liver. Liver Transpl (2014) 2.01
Platelet activation by oxidized low density lipoprotein is mediated by CD36 and scavenger receptor-A. Arterioscler Thromb Vasc Biol (2007) 1.85
Minimal effects of acute liver injury/acute liver failure on hemostasis as assessed by thromboelastography. J Hepatol (2011) 1.85
Results of pancreaticoduodenectomy in patients with periampullary adenocarcinoma: perineural growth more important prognostic factor than tumor localization. Ann Surg (2008) 1.79
An increased coronary risk is paradoxically associated with common cholesteryl ester transfer protein gene variations that relate to higher high-density lipoprotein cholesterol: a population-based study. J Clin Endocrinol Metab (2006) 1.75
Report of the Paris consensus meeting on expanded criteria donors in liver transplantation. Liver Transpl (2008) 1.75
Platelet transfusion during liver transplantation is associated with increased postoperative mortality due to acute lung injury. Anesth Analg (2009) 1.70
Long-term results of urgent revascularization for hepatic artery thrombosis after pediatric liver transplantation. Liver Transpl (2010) 1.68
Normal to increased thrombin generation in patients undergoing liver transplantation despite prolonged conventional coagulation tests. J Hepatol (2009) 1.65
Variation in bleomycin hydrolase gene is associated with reduced survival after chemotherapy for testicular germ cell cancer. J Clin Oncol (2008) 1.63
The glycoprotein Ib-IX-V complex contributes to tissue factor-independent thrombin generation by recombinant factor VIIa on the activated platelet surface. Blood (2008) 1.59
The VEGF +405 CC promoter polymorphism is associated with an impaired prognosis in patients with chronic heart failure: a MERIT-HF substudy. J Card Fail (2005) 1.56
Collagens are functional, high affinity ligands for the inhibitory immune receptor LAIR-1. J Exp Med (2006) 1.56
Who should get a liver graft? J Hepatol (2009) 1.56
Cell-collagen interactions: the use of peptide Toolkits to investigate collagen-receptor interactions. Biochem Soc Trans (2008) 1.56
Coagulation disorders and hemostasis in liver disease: pathophysiology and critical assessment of current management. Hepatology (2006) 1.50
Immediate postoperative low platelet count is associated with delayed liver function recovery after partial liver resection. Ann Surg (2010) 1.50
Interlaboratory variability in assessment of the model of end-stage liver disease score. Liver Int (2008) 1.50
Rebalanced hemostasis in patients with liver disease: evidence and clinical consequences. Blood (2010) 1.49
Prophylactic anticoagulation for venous thromboembolism in hospitalized cirrhosis patients is not associated with high rates of gastrointestinal bleeding. Liver Int (2013) 1.47
Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci. Nat Genet (2010) 1.43
Dearterialization of the liver causes intrahepatic cholestasis due to reduced bile transporter expression. Transplantation (2008) 1.43
Liver transplantation for unresectable hepatocellular carcinoma in normal livers. J Hepatol (2012) 1.42
The hemostatic status of pediatric recipients of adult liver grafts suggests that plasma levels of hemostatic proteins are not regulated by the liver. Blood (2010) 1.40
The significance of parenchymal changes of acute cellular rejection in predicting chronic liver graft rejection. Transplantation (2002) 1.38
Anastomotic biliary strictures after liver transplantation: causes and consequences. Liver Transpl (2006) 1.32
Biliary complications after liver transplantation: a review. Scand J Gastroenterol Suppl (2006) 1.31
Impact of blood loss on outcome after liver resection. Dig Surg (2007) 1.28
Elevated levels of von Willebrand Factor in cirrhosis support platelet adhesion despite reduced functional capacity. Hepatology (2006) 1.28
Association between Toll-like receptor 4 and inflammatory bowel disease. Inflamm Bowel Dis (2005) 1.24
Serum chemokine levels in Hodgkin lymphoma patients: highly increased levels of CCL17 and CCL22. Br J Haematol (2008) 1.22
Prevalence of hepatitis E virus infection in liver transplant recipients. Liver Transpl (2009) 1.21
Genetic susceptibility has a more important role in pediatric-onset Crohn's disease than in adult-onset Crohn's disease. Inflamm Bowel Dis (2007) 1.20
Causes and consequences of ischemic-type biliary lesions after liver transplantation. J Hepatobiliary Pancreat Surg (2006) 1.17
Venous thrombosis risk associated with plasma hypofibrinolysis is explained by elevated plasma levels of TAFI and PAI-1. Blood (2010) 1.16
Matrix metalloproteinase 2 genotype is associated with nonanastomotic biliary strictures after orthotopic liver transplantation. Liver Int (2011) 1.15
Nonanastomotic biliary strictures after liver transplantation, part 2: Management, outcome, and risk factors for disease progression. Liver Transpl (2007) 1.12
Three ulcerative colitis susceptibility loci are associated with primary sclerosing cholangitis and indicate a role for IL2, REL, and CARD9. Hepatology (2011) 1.09
Treatment of chronic hepatitis E in liver transplant recipients with pegylated interferon alpha-2b. Liver Transpl (2010) 1.09
Decreased in vitro anticoagulant potency of Rivaroxaban and Apixaban in plasma from patients with cirrhosis. Hepatology (2015) 1.08
The combination of primary sclerosing cholangitis and CCR5-Δ32 in recipients is strongly associated with the development of nonanastomotic biliary strictures after liver transplantation. Liver Int (2010) 1.08
Recombinant factor VIIa in patients with coagulopathy secondary to anticoagulant therapy, cirrhosis, or severe traumatic injury: review of safety profile. Transfusion (2006) 1.07
The human leukocyte antigen class I region is associated with EBV-positive Hodgkin's lymphoma: HLA-A and HLA complex group 9 are putative candidate genes. Cancer Epidemiol Biomarkers Prev (2006) 1.07
Bleeding in liver surgery: prevention and treatment. Clin Liver Dis (2009) 1.06
Nonanastomotic biliary strictures after liver transplantation, part 1: Radiological features and risk factors for early vs. late presentation. Liver Transpl (2007) 1.03
Level and course of FEV1 in relation to polymorphisms in NFE2L2 and KEAP1 in the general population. Respir Res (2009) 1.03
Surgical treatment of renal cell cancer liver metastases: a population-based study. Ann Surg Oncol (2011) 1.02
Towards a rational use of low-molecular-weight heparin in patients with cirrhosis. Liver Int (2011) 1.02
Excellent survival after liver transplantation for isolated polycystic liver disease: an European Liver Transplant Registry study. Transpl Int (2011) 1.02
Influence of common variants near INSIG2, in FTO, and near MC4R genes on overweight and the metabolic profile in adolescence: the TRAILS (TRacking Adolescents' Individual Lives Survey) Study. Am J Clin Nutr (2009) 1.01
Role of fibrin sealants in liver surgery. Dig Surg (2012) 1.01
Platelets in liver transplantation: friend or foe? Liver Transpl (2008) 0.99
Validation of the donor risk index in orthotopic liver transplantation within the Eurotransplant region. Liver Transpl (2012) 0.99
Protection of bile ducts in liver transplantation: looking beyond ischemia. Transplantation (2011) 0.98
Expression of heme oxygenase-1 in human livers before transplantation correlates with graft injury and function after transplantation. Am J Transplant (2005) 0.98
Possible association between telomere length and renal dysfunction in patients with chronic heart failure. Am J Cardiol (2008) 0.97
Smoking behavior in liver transplant recipients. Liver Transpl (2009) 0.97
Minimizing blood loss in liver transplantation: progress through research and evolution of techniques. Dig Surg (2005) 0.96
Topical haemostatic agents in liver surgery: do we need them? HPB (Oxford) (2009) 0.95
Liver transplantation with preservation of the inferior vena cava. A comparison of conventional and piggyback techniques in adults. Clin Transplant (2004) 0.95
Restenosis after percutaneous coronary intervention is associated with the angiotensin-II type-1 receptor 1166A/C polymorphism but not with polymorphisms of angiotensin-converting enzyme, angiotensin-II receptor, angiotensinogen or heme oxygenase-1. Pharmacogenet Genomics (2006) 0.95
Recombinant factor VIIa restores aggregation of alphaIIbbeta3-deficient platelets via tissue factor-independent fibrin generation. Blood (2003) 0.95
An unbalance between von Willebrand factor and ADAMTS13 in acute liver failure: implications for hemostasis and clinical outcome. Hepatology (2013) 0.94
Plasma levels of fibrinolytic proteins and the risk of myocardial infarction in men. Blood (2010) 0.93
P53 mutation analysis of colorectal liver metastases: relation to actual survival, angiogenic status, and p53 overexpression. Clin Cancer Res (2005) 0.93
Comparison of effects of VDR versus PXR, FXR and GR ligands on the regulation of CYP3A isozymes in rat and human intestine and liver. Eur J Pharm Sci (2009) 0.93
A benefit-risk review of systemic haemostatic agents: part 1: in major surgery. Drug Saf (2008) 0.93
Extrahepatic bile duct resection in combination with liver resection for hilar cholangiocarcinoma: a report of 42 cases. J Gastrointest Surg (2004) 0.93
Colorectal cancer and the CHEK2 1100delC mutation. Genes Chromosomes Cancer (2005) 0.92
Hepatic expression of ABC transporters G5 and G8 does not correlate with biliary cholesterol secretion in liver transplant patients. Hepatology (2005) 0.91
Established and new-generation antithrombotic drugs in patients with cirrhosis - possibilities and caveats. J Hepatol (2013) 0.90
Altered bile composition after liver transplantation is associated with the development of nonanastomotic biliary strictures. J Hepatol (2008) 0.90